ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA), BTRS Holdings Inc. (Nasdaq –

BALA CYNWYD, Pa., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

LogicBio Therapeutics, Inc. (Nasdaq – LOGC)

Under the terms of the merger agreement, LogicBio will be acquired by Alexion, AstraZeneca Rare Disease (“Alexion”). Shareholders of LogicBio will receive $2.07 in cash for each share of the Company they own. The investigation concerns whether the LogicBio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Alexion is paying too little for the Company. For example, the deal consideration is less than the 52-week high of $4.54 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/logicbio-therapeutics-inc-nasdaq-logc/.

O2Micro International Limited (Nasdaq – OIIM)

Under the terms of the agreement, O2Micro will be acquired by FNOF Precious Honour Limited (“FNOF”). Each ADS of the Company, representing fifty ordinary shares, will be exchanged for the right to receive $5.00 in cash per ADS without interest. The investigation concerns whether the O2Micro Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether FNOF is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/o2micro-international-limited-nasdaq-oiim/.

Coffee Holding Co., Inc. (Nasdaq – JVA)

Under the terms of the agreement, Coffee Holdings will merge with Delta Corp Holdings Limited (“Delta”). Shareholders of Delta are anticipated to collectively own approximately 95.21% of the outstanding ordinary shares and Coffee Holding shareholders immediately prior to the closing of the transaction are anticipated to collectively own approximately 4.79% of the outstanding ordinary shares. The investigation concerns whether the Coffee Holding Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/coffee-holding-co-inc-nasdaq-jva/.

BTRS Holdings Inc. (Nasdaq – BTRS)

Under the terms of the agreement, BTRS will be acquired by EQT X fund (“EQT Private Equity”) for $9.50 per share in cash for each outstanding share of common stock held. The transaction is valued at approximately $1.7 billion. The investigation concerns whether the BTRS Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether EQT Private Equity is paying too little for the Company. For example, the 52-week high for the Company’s shares was $11.01.

Additional information can be found at https://www.brodskysmith.com/cases/btrs-holdings-inc-nasdaq-btrs/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.